ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.33
0.42%
US Tech 100
21,108.40
1.14%
S&P 500
6,049.24
0.88%
US Dollar vs CAD
1.43345
-0.06%
Bitcoin
105,810.98
-0.34%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. 4 SC AG (VSC) Share Price

4 SC AG

4 SC AG (VSC)

Vanguard Canadian Short Term Corporate Bond Index ETF
5.90
0.08
(1.37%)
Closed January 21 3:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
5.90
Bid
5.70
Ask
6.10
Volume
996
5.62 Day's Range 6.10
3.82 52 Week Range 10.30
Market Cap
59.673M
Previous Close
5.82
Open
5.62
Last Trade
100
@
5.78
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,282
Shares Outstanding
10,114,009
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
304k
Net Profit
-8.24M

About 4 SC AG

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.4sc.com
Headquarters
Munich, Deu
Founded
-
4 SC AG is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker VSC. The last closing price for 4 SC was 5.82 €. Over the last year, 4 SC shares have traded in a share price range of 3.82 € to 10.30 €.

4 SC currently has 10,114,009 shares outstanding. The market capitalization of 4 SC is 58.86 € million.

Ask ADVFN Intelligence (AI)

VSC Latest News

More News

4SC's Anti-Cancer Compound Resminostat Receives Positive Opinion for Orphan Medicinal Product Designation in Europe to Treat ...

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the...

October 13 2011
Business Wire

4SC's Resminostat receives FDA Orphan Drug Status for Hodgkin's Lymphoma

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US...

September 26 2011
Business Wire

European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC's Resminostat to Treat Hep...

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the...

July 26 2011
Business Wire

FDA Grants Orphan Drug Designation to 4SC's Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma

4SC AG (FWB:VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the US Food and Drug...

July 12 2011
Business Wire

4SC Announces Topline Results of Phase IIb Trial of Vidofludimus in Rheumatoid Arthritis

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results...

June 08 2011
Business Wire

EULAR 2011 - Vidofludimus Superior to Cyclophosphamide and MMF in an Experimental Systemic Lupus Erythematosus Model

4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data...

May 27 2011
Business Wire

4SC's Vidofludimus Inhibits IL-17 Production by Interference With the JAK/STAT and NF-B Pathways

4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, has presented novel data on the mechanism of...

May 09 2011
Business Wire

4SC and Yakult Honsha Announce Exclusive License Agreement for Japan for the Oral HDAC Inhibitor Resminostat

4SC AG (Frankfurt, Prime Standard: VSC) and Yakult Honsha Co.; Ltd. (Tokyo: 2267) today announced the grant of an exclusive license by 4SC to Yakult Honsha for the development...

April 14 2011
Business Wire

4SC Announces Treatment of First Patient in Phase I TOPAS Study with the selective HDAC inhibitor 4SC-202

4SC (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that the first patient has been treated in the Phase I TOPAS study with 4SC-202...

April 13 2011
Business Wire

4SC Announces Financial Results 2010

4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced its financial results in...

March 29 2011
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.800000115.68627677825.09999996.18522885.52884286DE
41.8947.13216957614.016.43.8246855.23737341DE
12-0.36-5.750798722046.266.523.8222825.06046743DE
261.3529.67032967034.559.53.8224215.63223572DE
52-4.4-42.718446601910.310.33.8221956.68711014DE
1562.4973.02052785923.4111.21.1725695.16132412DE
2603.53148.9451476792.3711.21.0562672.59649782DE

VSC - Frequently Asked Questions (FAQ)

What is the current 4 SC share price?
The current share price of 4 SC is 5.90 €
How many 4 SC shares are in issue?
4 SC has 10,114,009 shares in issue
What is the market cap of 4 SC?
The market capitalisation of 4 SC is EUR 58.86M
What is the 1 year trading range for 4 SC share price?
4 SC has traded in the range of 3.82 € to 10.30 € during the past year
What is the reporting currency for 4 SC?
4 SC reports financial results in EUR
What is the latest annual turnover for 4 SC?
The latest annual turnover of 4 SC is EUR 304k
What is the latest annual profit for 4 SC?
The latest annual profit of 4 SC is EUR -8.24M
What is the registered address of 4 SC?
The registered address for 4 SC is FRAUNHOFERSTR. 22, PLANEGG-MARTINSRIED, MUNICH, 82152
What is the 4 SC website address?
The website address for 4 SC is www.4sc.com
Which industry sector does 4 SC operate in?
4 SC operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UE22US Energy Corp
3.70 €
(65.18%)
37.41k
432Arbor Metals Corp
0.55 €
(60.35%)
3.24M
3PJ1Golden Dory Resourses
0.044 €
(46.67%)
108k
7FJQuebec Innovative Materials Corp
0.095 €
(45.04%)
107.55k
DZJCountry Garden Holdings Co Ltd
0.0698 €
(41.87%)
101.25k
E3O1Nexoptic Technology Corp
0.0075 €
(-51.61%)
9.58k
K1SNKlondike Silver Corporation
0.006 €
(-47.83%)
11k
L7C2Windfall Geotek Inc
0.005 €
(-41.18%)
10.14k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-36.36%)
60k
PA8Paion AG
0.0152 €
(-34.48%)
14.41k
PF8European Lithium Limited
0.044 €
(-8.71%)
9.81M
D7GNel ASA
0.1948 €
(-2.11%)
5.12M
432Arbor Metals Corp
0.55 €
(60.35%)
3.24M
1NWNeptune Digital Assets Corp
1.06 €
(17.52%)
1.64M
RQ0DWave Quantum Inc
6.022 €
(9.77%)
1.44M

Discussion

View Full Feed
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 3 minutes ago
$TANH >>> More news out! $$$$$$$$

Tantech Holdings Ltd. (TANH) Subsidiary Registers U.S. Trademark

News provided by
Tantech Holdings Ltd.
Jan 21, 2025, 08:30 ET

LISHUI, China, Jan. 21, 2025 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ:
MFI TANH
gitreal gitreal 3 minutes ago
Do you understand this?

........8 billion shares headed your way.

Soon.
NBRI
blackhawks blackhawks 3 minutes ago
Morgan Freeman, narrator par excellence.

[yt]BhGdTcJqlBw[/yt]
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 4 minutes ago
$TANH >>> More news out! $$$$$$$$

Tantech Holdings Ltd. (TANH) Subsidiary Registers U.S. Trademark

News provided by
Tantech Holdings Ltd.
Jan 21, 2025, 08:30 ET

LISHUI, China, Jan. 21, 2025 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ:
MFI TANH
RickNagra RickNagra 4 minutes ago
Calamari flip flops more than a pair of flip flops.  He talks from both sides of his mouth.  His left and right jaw muscles get an even workout.
FNMA
Fully Diluted Fully Diluted 4 minutes ago
Bessent's answers are now available. The Senate Committee on Finance asked Bessent these questions in advance of the confirmation hearing.

Questions 68-84 relate directly to the ending of Fannie and Freddie conservatorships.
https://www.finance.senate.gov/imo/media/doc/respons
FNMA
Zorax Zorax 5 minutes ago
He's saving the whales of Utah.

Actually, he's just doing what the oil oligarch's ordered him to do.
manibiotech manibiotech 5 minutes ago
Probably talk about mRNA during stargate project press conference 
NWBO
TightCoil TightCoil 6 minutes ago
Forget Release
Being Re-Listed will get our PPS
up more and quicker
FNMA
Zorax Zorax 7 minutes ago
Here we go again, calling his criminality 'courageous'.

“He did not have to do this. He had a lot of opposition within his own party,” Pierce said. “I do think it showed a lot of courage by President Trump to pardon everybody, so we are obviously grateful for that.” Pierce said cleme
Don Faton Don Faton 8 minutes ago
Still here still waiting 
SRNW
Don Faton Don Faton 8 minutes ago
Holy man. Are we getting a name change before or after man goes to mars ?   
WNFT
3331 3331 8 minutes ago
If you're not an investor, then why do you spend so much time here? SHOO, BE GONE! You have nothing to contribute, and have zero investment knowledge.

Savvy investors recognize an Apple/Amazon opportunity (I owned both but sold way too soon) when they see one, and BIEL is that OPPOR
BIEL
blackhawks blackhawks 9 minutes ago
Yeah, pinned inside the 20 is probably most impressive as it seems to me to be the main objective for a punter. But for a 4th round pick he needs to show more in the other stats this year
delerious1 delerious1 9 minutes ago
Hey thanks but sorry I don't understand the question..... habla ingles ?
NBRI
sctts sctts 9 minutes ago
The tweet was interesting, if they completely gave up on MVNT, why tweet from that account.
MVNT
Guido2 Guido2 9 minutes ago
My response to Joe Light:

https://x.com/guidoperei/status/1881895463298957649?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
mascale mascale 10 minutes ago
So years of "Miro" connected data are waterchaser poster now reported, in some record, as is routine. There is no waterchaser supportive data, anywhere noted.
HIRU
ice_n_ak ice_n_ak 10 minutes ago
Why is this ticker still trading? Is there still a company? For that matter, why is the moon made of cheese?
GERS
bas2020 bas2020 11 minutes ago
Who cares? Wrong board.
NWBO
4retire 4retire 11 minutes ago
From PennyWorld on NVDA’s board:

AI Engine ChatGPT assessed the key companies benefiting from this new $ 500B initiative. NVDA is at the top of the list...

ChatGPT search results.....

President Donald Trump's recent announcement of the $500 billion Starga
NVDA
Toronto_Trader Toronto_Trader 11 minutes ago
Until we see an updated share structure posted, we may have seen tens of millions of shares added recently. If not, this may be poised to run.

$KOAN
KOAN
fuagf fuagf 12 minutes ago
Nowhere to go, nowhere to hide. Had to be lucky to survive. Humans had no answer but immunity to microscopic bacteria. Maybe that's why Trump put Kennedy in charge of health, to help boost the virus and bacteria count on earth. Meanwhile, good people strive to handle the virus ETrumpee.
GoodGuyBill GoodGuyBill 12 minutes ago
Anyone knows what's going on with Moderna?

https://investorshub.advfn.com/uimage/uploads/2025/1/21/kasozScreenshot_2025-01-21_204012.jpg
NWBO

Your Recent History

TG
VSC
4 SC
NYSE
COHR
Coherent
FX
CADARS
CAD vs ARS
BOV
VGIR12
Valora Re Iii Fundo DE I...
POLO
CUDOSUSDT
CudosToken
DOWI
DJICH1MP
DJ Islamic Market China ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads